Please check your internet connection and try again.
# Diclofenac (Oral)
## Overview
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation.
## Primary Indications
* Pain associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.
* Acute pain.
## Adult Dosing
* **Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis:** 150 mg/day divided into 2 or 3 doses (e.g., 50 mg twice daily or 75 mg twice daily). Maximum recommended daily dose is 225 mg.
* **Acute Pain:** Initial dose of 50 mg, followed by 50 mg every 8 hours as needed. Maximum daily dose is 150 mg.
## Pediatric Dosing
* Information on oral diclofenac pediatric dosing is limited and not well-established for all indications. Specific pediatric dosing should be determined by a healthcare provider based on the indication and patient's weight.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Mild to moderate impairment may not require dose adjustment, but the lowest effective dose should be used. Avoid in severe hepatic impairment.
* **Renal Impairment:** Use with caution. Patients with mild to moderate renal impairment may require a dose reduction. Avoid in severe renal impairment.
## Contraindications
* Hypersensitivity to diclofenac, aspirin, or other NSAIDs.
* History of bronchospasm, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
* Concomitant use with other NSAIDs.
## Adverse Effects
* **Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, constipation, dyspepsia), abdominal pain, headache, dizziness, rash, edema.
* **Serious:** Cardiovascular thrombotic events (myocardial infarction, stroke), gastrointestinal bleeding, ulceration, perforation, hepatic enzyme elevations, renal impairment, anaphylaxis.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin):** Increased risk of bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Other NSAIDs (including aspirin):** Increased risk of GI toxicity and other adverse effects.
* **ACE Inhibitors/ARBs:** May reduce antihypertensive effect and increase risk of renal impairment.
* **Diuretics:** May reduce diuretic effect and increase risk of renal impairment.
* **Lithium:** Increased serum lithium levels.
* **Methotrexate:** Increased risk of methotrexate toxicity.
* **SSRIs/SNRIs:** Increased risk of bleeding.
## Monitoring
* Monitor for signs and symptoms of gastrointestinal bleeding (e.g., melena, hematemesis).
* Monitor blood pressure, especially in patients with hypertension.
* Monitor renal function (BUN, creatinine) and liver function (LFTs) periodically, particularly in patients with pre-existing renal or hepatic disease.
* Assess for signs of cardiovascular events.
## Clinical Pearls
* Use the lowest effective dose for the shortest duration necessary to minimize the risk of serious adverse effects.
* Administer with food or milk to reduce gastrointestinal upset.
* Consider gastroprotection (e.g., PPI) in patients at increased risk for GI events.
* Be aware of the increased risk of cardiovascular events and GI bleeding associated with NSAID use.
***
*This information is intended for clinical use and does not replace the need to consult the most current prescribing information and institutional protocols.*